Congo vs South Sudan: Hepatitis B surface antigen (HBsAg) prevalence
Congo
1.6%
in 2024
South Sudan
1.7%
in 2024
Congo rank
18th
South Sudan rank
17th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Congo
- South Sudan
How they compare
South Sudan currently reports 1.7% against 1.6% in Congo, a difference of 0.1%.
That makes South Sudan's figure about 1.1 times Congo's.
Across all 10 years both countries report, South Sudan has been ahead every year.
Congo ranks 18th and South Sudan ranks 17th of 194 countries.
South Sudan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.6% | 4.2% | 2.6% | South Sudan |
| 2020s | 1.6% | 2.2% | 0.6% | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Congo or South Sudan?
- South Sudan, at 1.7% against 1.6% in Congo as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Congo and South Sudan?
- 0.1%, with South Sudan ahead.
- How many years of comparable data are there for Congo and South Sudan?
- 10 years are reported by both, from 2015 to 2024.
- How do Congo and South Sudan rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Congo ranks 18th and South Sudan ranks 17th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.